These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12021645)

  • 61. Managing Graves' orbitopathy.
    Coday MP; Dallow RL
    Int Ophthalmol Clin; 1998; 38(1):103-15. PubMed ID: 9532475
    [No Abstract]   [Full Text] [Related]  

  • 62. Hypofractionated radiotherapy for Graves' orbitopathy.
    Heyd R; Strassmann G; Herkströter M; Martin T; Zamboglou N
    Rontgenpraxis; 2001; 54(3):94-100. PubMed ID: 11799870
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Orbital radiotherapy for thyroid eye disease.
    Dolman PJ; Rath S
    Curr Opin Ophthalmol; 2012 Sep; 23(5):427-32. PubMed ID: 22729183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ophthalmological diagnosis in autoimmune orbitopathy.
    Boergen KP
    Exp Clin Endocrinol; 1991 May; 97(2-3):235-42. PubMed ID: 1915640
    [No Abstract]   [Full Text] [Related]  

  • 65. [Value of irradiation of the base of the orbit in patients with malignant exophthalmia. Experience of the Jules Bordet Institute 1974-1983].
    Regnier R; Conreur L; Schrooyen M; Glinoer D; Lemort M; Massant B
    Rev Med Brux; 1986 Sep; 7(7):419-25. PubMed ID: 2429357
    [No Abstract]   [Full Text] [Related]  

  • 66. Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy.
    Gerling J; Kommerell G; Henne K; Laubenberger J; Schulte-Mönting J; Fells P
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):182-9. PubMed ID: 12504052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Infrared thermovision findings in a patient with infiltrating orbitopathy].
    Kohlmann H; Storch H; Lommatzsch PK
    Klin Monbl Augenheilkd; 1989 Mar; 194(3):190-5. PubMed ID: 2724862
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intraocular pressure changes after treatment for Graves' orbitopathy.
    Danesh-Meyer HV; Savino PJ; Deramo V; Sergott RC; Smith AF
    Ophthalmology; 2001 Jan; 108(1):145-50. PubMed ID: 11150280
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radiobiological mechanisms of anti-inflammatory radiotherapy.
    Trott KR; Kamprad F
    Radiother Oncol; 1999 Jun; 51(3):197-203. PubMed ID: 10435813
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultrasonography of the orbit.
    Dallow RL
    Int Ophthalmol Clin; 1986; 26(3):51-76. PubMed ID: 3536788
    [No Abstract]   [Full Text] [Related]  

  • 71. Clinical presentation of thyroid associated orbitopathy.
    Kendall-Taylor P; Perros P
    Thyroid; 1998 May; 8(5):427-8. PubMed ID: 9623736
    [No Abstract]   [Full Text] [Related]  

  • 72. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
    Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H
    Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of the eyebrow fat pad in Graves' orbitopathy.
    Goldberger S; Sarraf D; Bernstein JM; Hurwitz JJ
    Ophthalmic Plast Reconstr Surg; 1994 Jun; 10(2):80-6. PubMed ID: 8086367
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Torsional diplopia after transantral orbital decompression and extraocular muscle surgery associated with Graves' orbitopathy.
    Kushner BJ
    Am J Ophthalmol; 1992 Aug; 114(2):239-40. PubMed ID: 1642313
    [No Abstract]   [Full Text] [Related]  

  • 75. Correlation between computed tomography and magnetic resonance imaging in Graves' orbitopathy.
    Nianiaris N; Hurwitz JJ; Chen JC; Wortzman G
    Can J Ophthalmol; 1994 Feb; 29(1):9-12. PubMed ID: 8180879
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 77. Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why?
    Marcocci C; Bartalena L; Bruno-Bossio G; Vanni G; Cartei F; Bogazzi F; Pinchera A
    Dev Ophthalmol; 1993; 25():131-41. PubMed ID: 8359348
    [No Abstract]   [Full Text] [Related]  

  • 78. [Orbital disease and hyperthyroidism. Means syndrome. Apropos of 2 cases].
    Maurin JF; Burlaton J; Auduge A; Ocamica P; Renard JP; Jallon P; Bourgeois H
    Ophtalmologie; 1988 Oct; 2(4):369-71. PubMed ID: 3247211
    [No Abstract]   [Full Text] [Related]  

  • 79. The aftermath of orbital radiotherapy for graves' ophthalmopathy.
    Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Buettner H; Robertson DM; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
    Ophthalmology; 2002 Nov; 109(11):2100-7. PubMed ID: 12414422
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Re: "Radiographic analysis of extraocular muscle volumetric changes in thyroid-related orbitopathy following orbital decompression".
    Rajabi MT; Tabatabaie SZ; Rajabi MB
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):143-4; author reply 144. PubMed ID: 21378518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.